Apr. 22 at 10:39 PM
$CMRX On April 21, 2025, the Company completed its previously announced acquisition of Chimerix.
The tender offer by Pinetree Acquisition Sub, Inc., a Delaware corporation (“Purchaser”), an indirect wholly owned subsidiary of Jazz, for all of
the outstanding shares of common stock, par value
$0.001 per share, of Chimerix (the “Shares”) expired at one minute after 11:59 p.m., Eastern Time,
on April 17, 2025. Jazz has accepted for payment of
$8.55 per Share, in cash, without interest and subject to reduction for any applicable withholding
taxes (the “Offer Price”), all Shares that were validly tendered and not validly withdrawn.
Following its acceptance of the tendered Shares, Jazz completed the acquisition through a merger of Purchaser with and into Chimerix (the
“Merger”). As a result of the Merger, the separate existence of Purchaser ceased, and Chimerix continued as the surviving corporation and an indirect
wholly owned subsidiary of Jazz.
